Advertising, Entertainment & Media
Royal Dutch Shell has been ordered to withdraw an advertisement in the Netherlands that sought to portray the oil giant as environmentally friendly, and British authorities said Thursday they had opened a formal investigation in the case.
The Defense Department will pay private U.S. contractors in Iraq up to $300 million over the next three years to produce news stories, entertainment programs and public service advertisements for the Iraqi media in an effort to "engage and inspire" the local population to support U.S. objectives and the Iraqi government.
Scientists working for the chromium industry withheld data about the metal's health risks while the industry campaigned to block strict new limits on the cancer-causing chemical, according to a scientific journal report published yesterday.
High levels of toxic lead turning up in cheap jewelry from China are prompting recalls in the U.S. But some of the lead used by these Chinese manufacturers comes from an unconventional source: computers and other electronic goods discarded in Western countries and dumped in China.
In the face of criticism over its controversial construction projects, Bechtel has taken media manipulation to the next level, employing a three-pronged approach to weaving a rosy story for the public and investors.
From exclusive soft-drink contracts to computers displaying continuous advertising, corporate marketing in public schools is rising sharply. But few states have laws in place to address the phenomenon, and most decisions on commercial arrangements in schools are made piecemeal by local officials, according to a report from the General Accounting Office scheduled to be released today.
According to a proposal, PhRMA was to pay Phoenix a six-figure sum for the marketing and production of a written-to-order fictional thriller. The plotline was what Hollywood would term high-concept - a group of shadowy terrorists conspires to murder thousands of Americans by poisoning the medicine they're importing from Canada to beat U.S. drug prices. PhRMA subsequently pulled the plug on the deal.